Close Menu

Susan Desmond-Hellman has been chancellor of the University of California, San Francisco, for about two years now. She moved to the university after a successful career in the pharmaceutical industry, and is determined to make the school as famous in the eyes of the public as the Mayo Clinic for innovative biomedical research, The New York Times' Denise Grady says. Grady recently spoke with Desmond-Hellman, UCSF's first female chancellor.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.